 |
|
adenovirus HER2-transduced autologous dendritic cell vaccine
A cell-based cancer vaccine composed of autologous dendritic cells (DCs) transduced with a replication-deficient adenovirus vector encoding HER-2 with potential antineoplastic activity. Upon administration, adenovirus HER2-transduced autologous dendritic cell vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against HER-2-positive tumor cells, which may result in tumor cell death and decreased tumor growth.
HER-2, a tyrosine kinase receptor for epidermal growth factor (EGF) (also known as neu and ErbB2), is overexpressed by some breast, ovarian, and gastric cancers. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Previous: | adenoviral vector encoding HSV thymidine kinase, adenovirus 5-tumor necrosis factor alpha, adenovirus B7-1, adenovirus encoding human aquaporin-1, adenovirus encoding recombinant human endostatin | | Next: | adenovirus vector, adenovirus-interferon-gamma TG1042, ADH-1, adipose-derived regenerative cells, adozelesin |
|
|
